Zydus Settles On Revlimid In US

Agreement Brings To An End Indian Firm's Lenalidomide Litigation

 
• By Dave Wallace

Zydus Cadila has settled US patent litigation with Celgene over its proposed lenalidomide generic, marking the latest in a line of settlements over the Revlimid brand.

Legal Settlement Handshake
Zydus and Celgene have settled over lenalidomide • Source: Shutterstock

Zydus Cadila and Celgene have settled US patent litigation over Revlimid (lenalidomide), the Indian company has announced.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legal & IP

More from Generics Bulletin